The recent emergence of nanomedicine has revolutionized the therapeutic landscape and
necessitated the creation of more sophisticated drug delivery systems. Polymeric …

Biomolecule-based nanostructures are inherently multifunctional and harbour diverse
biological activities, which can be explored for cancer nanomedicine. The supramolecular …

Insufficient drug loading and leakage of payload remain major challenges in designing
liposome-based drug delivery systems. These phenomena can limit duration of effect and …

Effective anticancer nanomedicines need to exhibit prolonged circulation in blood, to
extravasate and accumulate in tumours, and to be taken up by tumour cells. These …

Cancer therapies often have narrow therapeutic indexes and involve potentially suboptimal
combinations due to the dissimilar physical properties of drug molecules. Nanomedicine …

Carriers are equally important as drugs. They can substantially improve bioavailability of
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …

The success of oil-based plastics and the continued growth of production and utilisation can
be attributed to their cost, durability, strength to weight ratio, and eight contributions to the …

Advances in biomaterials for drug delivery are enabling significant progress in biology and
medicine. Multidisciplinary collaborations between physical scientists, engineers, biologists …

The development of nanoparticle-based drug formulations has yielded the opportunities to
address and treat challenging diseases. Nanoparticles vary in size but are generally ranging …

Chronic, non-healing wounds place a significant burden on patients and healthcare
systems, resulting in impaired mobility, limb amputation, or even death. Chronic wounds …